Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

Investigator diagnosis of staged III or IV NSCLC
Age 18 to 70 years
ECOG performance status ≤ 1
Chemotherapy naïve
Body weight ≥ 45kg
Hemoglobin ≥ 100g/L; white blood cell ≥ 4.0×109/L; absolute neutrophil count ≥1.5 × 109/L; platelet count ≥ 100 × 109/L
Alanine transarninase ≤1.5×ULN; aspartate aminotransferase ≤1.5×ULN; serum creatinine ≤1.5×ULN; total bilirubin ≤1.5×ULN

A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy